37.27
price up icon0.57%   0.21
pre-market  プレマーケット:  37.02   -0.25   -0.67%
loading
前日終値:
$37.06
開ける:
$37
24時間の取引高:
1.98M
Relative Volume:
0.51
時価総額:
$15.70B
収益:
$2.26B
当期純損益:
$1.09B
株価収益率:
15.91
EPS:
2.3431
ネットキャッシュフロー:
$2.70B
1週間 パフォーマンス:
+3.24%
1か月 パフォーマンス:
+3.90%
6か月 パフォーマンス:
+16.65%
1年 パフォーマンス:
+29.86%
1日の値動き範囲:
Value
$36.76
$37.56
1週間の範囲:
Value
$35.88
$37.56
52週間の値動き範囲:
Value
$24.05
$37.56

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
名前
Royalty Pharma Plc
Name
セクター
Healthcare (1159)
Name
電話
(212) 883-0200
Name
住所
110 EAST 59TH STREET, NEW YORK, NY
Name
職員
99
Name
Twitter
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
RPRX's Discussions on Twitter

RPRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RPRX
Royalty Pharma Plc
37.27 15.62B 2.26B 1.09B 2.70B 2.3431
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.87B 3.81B -644.79M -669.77M -6.24

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-16 開始されました Morgan Stanley Overweight
2024-06-03 ダウングレード UBS Buy → Neutral
2022-06-14 再開されました UBS Buy
2022-05-13 開始されました Scotiabank Sector Outperform
2022-04-27 開始されました Goldman Buy
2022-04-14 アップグレード JP Morgan Neutral → Overweight
2022-04-06 再開されました Morgan Stanley Overweight
2021-10-29 アップグレード Citigroup Neutral → Buy
2021-07-30 開始されました Tigress Financial Buy
2020-11-09 アップグレード UBS Neutral → Buy
2020-07-14 開始されました Evercore ISI In-line
2020-07-13 開始されました BofA Securities Buy
2020-07-13 開始されました Citigroup Neutral
2020-07-13 開始されました Cowen Outperform
2020-07-13 開始されました Goldman Neutral
2020-07-13 開始されました JP Morgan Neutral
2020-07-13 開始されました Morgan Stanley Equal-Weight
2020-07-13 開始されました SunTrust Buy
2020-07-13 開始されました UBS Neutral
すべてを表示

Royalty Pharma Plc (RPRX) 最新ニュース

pulisher
Jul 29, 2025

Royalty Pharma plc stock volume spike explainedScalable Portfolio Growth Suggestions Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 22:21:39 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Machine Learning Models Forecast Royalty Pharma plc UptickConsistent Income Focused Trade List Analyzed - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Can Royalty Pharma plc Regain Momentum After BreakdownCommunity Shared Smart Money Signals Show Movement - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Bollinger Bands Expand on Royalty Pharma plc — Volatility AheadWeekly Chart Analysis With Entry Advice Provided - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Royalty Pharma stock hits 52-week high at 36.89 USD - Investing.com Australia

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Royalty Pharma plc stock attracting strong analyst attentionExceptional stock performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy Royalty Pharma plc stockSuperior portfolio returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Ridgewood Investments LLC Decreases Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Royalty Pharma plc stock price move sharplyInvest confidently with real-time updates - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Mediolanum International Funds Ltd Lowers Stake in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Position Trimmed by Allianz Asset Management GmbH - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Envestnet Asset Management Inc. Boosts Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Cwm LLC Increases Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

What is Royalty Pharma plc company’s growth strategyUnmatched profit growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Royalty Pharma plc compare to its industry peersCapitalize on strong market momentum - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Royalty Pharma plc stock overvalued or undervaluedUnlock powerful trading signals and alerts - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-28 08:51:02 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Royalty Pharma plcMaximize your portfolio’s earning potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Royalty Pharma plc stock expected to show significant growthDynamic profit opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What markets is GCLWW expanding into Is Royalty Pharma plc stock a good long term investment optionGet daily updates on promising stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Vestor Capital LLC Takes $12.60 Million Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 27, 2025
pulisher
Jul 26, 2025

Royalty Pharma (NASDAQ:RPRX) Sets New 12-Month HighHere's What Happened - MarketBeat

Jul 26, 2025
pulisher
Jul 26, 2025

Royalty Pharma: A High-Margin, Earnings-Driven Opportunity in the Biopharma Royalty Space - AInvest

Jul 26, 2025
pulisher
Jul 26, 2025

Baillie Gifford & Co. Has $417.21 Million Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Royalty Pharma plc stockFree Wealth Planning Blueprint - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Royalty Pharma plc Stock Analysis and ForecastSuperior portfolio returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Royalty Pharma plc a good long term investmentDouble-digit growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Royalty Pharma (NASDAQ:RPRX) Given New $42.00 Price Target at Citigroup - MarketBeat

Jul 25, 2025
pulisher
Jul 24, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Holdings Lifted by Los Angeles Capital Management LLC - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Shares Sold by New York State Common Retirement Fund - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Royalty Pharma Plc's (NASDAQ:RPRX) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Winners And Losers Of Q1: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Edgestream Partners L.P. Makes New $659,000 Investment in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Royalty Pharma plc stock pricePhenomenal wealth increase - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Citigroup maintains Buy rating, raises PT for Royalty Pharma to $42. - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Citi raises Royalty Pharma stock price target to $42 on CF and Tremfya growth By Investing.com - Investing.com South Africa

Jul 22, 2025
pulisher
Jul 22, 2025

Citi raises Royalty Pharma stock price target to $42 on CF and Tremfya growth - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Royalty Pharma (RPRX) PT Raised to $42 at Citi - StreetInsider

Jul 22, 2025

Royalty Pharma Plc (RPRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.38
price up icon 10.28%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
大文字化:     |  ボリューム (24 時間):